Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts.
Fiche publication
Date publication
juin 2024
Journal
ESMO open
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier
Tous les auteurs :
Hoang TCT, Debieuvre D, Bravard AS, Martinez S, Le Garff G, Jeandeau S, Petit L, Marquette D, Amrane K, Demontrond P, Tiercin M, Jarjour B, Turlotte A, Masson P, Jaafar M, Hauss PA, Morel H,
Lien Pubmed
Résumé
The impact of the most recent advances, including targeted therapies and immune checkpoint inhibitors, on early (3-month) mortality in lung cancer is unknown. The aims of this study were to evaluate the real-world rate of and risk factors for early mortality, as well as trends in early mortality over the last 20 years.
Mots clés
early mortality, lung cancer, mortality rate, non-small-cell lung cancer, risk factor
Référence
ESMO Open. 2024 06 6;9(6):103594